ArticleJournal of hepatology2009

Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.

Pippa Newell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.